Reuters logo
BRIEF-TherapeuticsMD provides additional information on TX-004HR regulatory update
April 19, 2017 / 11:11 AM / in 8 months

BRIEF-TherapeuticsMD provides additional information on TX-004HR regulatory update

April 19 (Reuters) - TherapeuticsMD Inc:

* TherapeuticsMD provides additional information on TX-004HR regulatory update

* TherapeuticsMD - expects FDA will finalize an action on NDA for TX-004HR on or before originally scheduled PDUFA target action date of May 7, 2017

* At this time, company is not aware of nature of deficiencies in NDA identified by FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below